Consolidated Standards of Reporting Trials

Consolidated Standards of Reporting Trials Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.

Translate to: East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski

The Consolidated Standards of Reporting Trials (CONSORT) is a set of guidelines aimed at improving the reporting quality of randomized controlled trials. It provides a standard way for researchers to describe the methodology and results of their trials, ensuring that the data can be accurately interpreted and verified by others in the scientific community.

Background

Randomized controlled trials (RCTs) are considered the gold standard for testing the efficacy and safety of new medical interventions. However, the value of an RCT depends significantly on the clarity and completeness of its reporting. In the past, inconsistencies and omissions in trial reports have led to difficulties in interpreting the results, potentially leading to incorrect conclusions about the effectiveness of interventions. The CONSORT guidelines were developed to address these issues.

Development and History

The CONSORT Statement was first published in 1996, with subsequent updates in 2001 and 2010 to reflect advances in methodological research and the evolving landscape of trial reporting. The guidelines were developed by a group of trialists, statisticians, epidemiologists, and biomedical editors, known as the CONSORT Group.

Guidelines

The CONSORT guidelines include a checklist and a flow diagram. The checklist consists of items focusing on the reporting of the trial's design, analysis, and interpretation. Key sections include:

• Title and abstract
• Introduction (background and objectives)
• Methods (trial design, participants, interventions, objectives, outcomes, sample size, randomization, blinding)
• Results (participant flow, recruitment, baseline data, numbers analyzed, outcomes and estimation, ancillary analyses, harms)
• Discussion (limitations, generalizability, interpretation)
• Other information (registration, protocol, funding)

The flow diagram provides a visual representation of the progress of participants through the trial, including recruitment, enrollment, randomization, intervention, and follow-up.

Impact

The adoption of the CONSORT guidelines has been associated with improvements in the quality of reports of randomized trials. Journals that endorse and enforce the CONSORT guidelines tend to publish trials with more complete and transparent reporting. This, in turn, facilitates critical appraisal and interpretation of the research by clinicians, researchers, and policymakers.

Challenges and Criticisms

Despite its benefits, the implementation of CONSORT guidelines is not without challenges. Some researchers have pointed out the difficulty in adhering to all the guidelines, especially in complex trials. Others have called for further refinement of the guidelines to address specific types of trials or interventions.

See Also

• Randomized controlled trial
• Evidence-based medicine
• Clinical trial protocol
• Peer review

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian